US Stock MarketDetailed Quotes

EVLO Evelo Biosciences

Watchlist

0.000
+0.000+33.33%

15min DelayClose Nov 4 16:00 ET

7.59KMarket Cap0.00P/E (TTM)

Evelo Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-64.24%10.39M

-39.30%17.96M

-13.36%24.9M

-6.01%108.47M

-23.48%21.09M

-11.18%29.05M

6.98%29.59M

4.61%28.74M

25.59%115.4M

-2.27%27.56M

Selling and administrative expenses

-45.40%3.89M

-41.25%4.92M

-25.21%7.04M

-5.80%29.91M

-42.35%5M

-29.52%7.13M

19.50%8.37M

57.92%9.42M

42.58%31.75M

42.61%8.68M

-General and administrative expense

-45.40%3.89M

-41.25%4.92M

-25.21%7.04M

-5.80%29.91M

-42.35%5M

-29.52%7.13M

19.50%8.37M

57.92%9.42M

42.58%31.75M

42.61%8.68M

Research and development costs

-70.36%6.5M

-38.54%13.04M

-7.58%17.86M

-6.08%78.55M

-14.81%16.08M

-2.97%21.93M

2.74%21.22M

-10.17%19.32M

20.15%83.64M

-14.62%18.88M

Operating profit

64.24%-10.39M

39.30%-17.96M

13.36%-24.9M

6.01%-108.47M

23.48%-21.09M

11.18%-29.05M

-6.98%-29.59M

-4.61%-28.74M

-25.59%-115.4M

2.27%-27.56M

Net non-operating interest income expense

-47.46%-1.16M

-34.22%-1.37M

-8.18%-1.11M

-29.35%-4.67M

-81.88%-1.84M

22.97%-788K

-25.31%-1.02M

-34.25%-1.03M

-71.27%-3.61M

-33.60%-1.01M

Non-operating interest expense

47.46%1.16M

34.22%1.37M

8.18%1.11M

29.35%4.67M

81.88%1.84M

-22.97%788K

25.31%1.02M

34.25%1.03M

71.27%3.61M

33.60%1.01M

Other net income (expense)

-34.80%-829K

-838.28%-1.54M

3,975.00%815K

83.25%-459K

-621.43%-73K

-486.79%-615K

106.80%209K

-87.65%20K

-471.27%-2.74M

-84.78%14K

Gain on sale of security

---9K

--4K

--627K

----

Special income (charges)

---793K

---1.62M

----

83.88%-520K

---520K

--0

----

---3.23M

--0

-Less:Impairment of capital assets

----

--1.62M

----

--0

----

-Less:Other special charges

----

-83.88%520K

----

--3.23M

--0

-Gain on sale of property,plant,equipment

---793K

----

--0

----

Other non- operating income (expenses)

95.61%-27K

-66.99%69K

840.00%188K

-87.45%61K

3,092.86%447K

-486.79%-615K

38.41%209K

-87.65%20K

-34.15%486K

-84.78%14K

Income before tax

59.35%-12.38M

31.34%-20.87M

15.29%-25.2M

6.69%-113.6M

19.46%-23M

9.28%-30.46M

3.64%-30.4M

-5.95%-29.75M

-30.55%-121.75M

1.06%-28.56M

Income tax

-115.89%-17K

42.94%233K

25.00%145K

117.29%930K

460.82%544K

-31.41%107K

207.55%163K

-4.92%116K

4.65%428K

-48.40%97K

Net income

59.55%-12.36M

30.95%-21.1M

15.14%-25.34M

6.26%-114.53M

17.84%-23.54M

9.39%-30.56M

3.28%-30.56M

-5.91%-29.86M

-30.44%-122.18M

1.37%-28.65M

Net income continuous Operations

59.55%-12.36M

30.95%-21.1M

15.14%-25.34M

6.26%-114.53M

17.84%-23.54M

9.39%-30.56M

3.28%-30.56M

-5.91%-29.86M

-30.44%-122.18M

1.37%-28.65M

Minority interest income

Net income attributable to the parent company

59.55%-12.36M

30.95%-21.1M

15.14%-25.34M

6.26%-114.53M

17.84%-23.54M

9.39%-30.56M

3.28%-30.56M

-5.91%-29.86M

-30.44%-122.18M

1.37%-28.65M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

59.55%-12.36M

30.95%-21.1M

15.14%-25.34M

6.26%-114.53M

17.84%-23.54M

9.39%-30.56M

3.28%-30.56M

-5.91%-29.86M

-30.44%-122.18M

1.37%-28.65M

Basic earnings per share

74.91%-1.42

53.16%-3.78

58.93%-4.6

43.29%-26.2

61.11%-4.2

55.08%-5.66

31.61%-8.07

-1.82%-11.2

2.53%-46.2

12.90%-10.8

Diluted earnings per share

74.91%-1.42

53.16%-3.78

58.93%-4.6

43.29%-26.2

61.11%-4.2

55.08%-5.66

31.61%-8.07

-1.82%-11.2

2.53%-46.2

12.90%-10.8

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-64.24%10.39M	-39.30%17.96M	-13.36%24.9M	-6.01%108.47M	-23.48%21.09M	-11.18%29.05M	6.98%29.59M	4.61%28.74M	25.59%115.4M	-2.27%27.56M
Selling and administrative expenses	-45.40%3.89M	-41.25%4.92M	-25.21%7.04M	-5.80%29.91M	-42.35%5M	-29.52%7.13M	19.50%8.37M	57.92%9.42M	42.58%31.75M	42.61%8.68M
-General and administrative expense	-45.40%3.89M	-41.25%4.92M	-25.21%7.04M	-5.80%29.91M	-42.35%5M	-29.52%7.13M	19.50%8.37M	57.92%9.42M	42.58%31.75M	42.61%8.68M
Research and development costs	-70.36%6.5M	-38.54%13.04M	-7.58%17.86M	-6.08%78.55M	-14.81%16.08M	-2.97%21.93M	2.74%21.22M	-10.17%19.32M	20.15%83.64M	-14.62%18.88M
Operating profit	64.24%-10.39M	39.30%-17.96M	13.36%-24.9M	6.01%-108.47M	23.48%-21.09M	11.18%-29.05M	-6.98%-29.59M	-4.61%-28.74M	-25.59%-115.4M	2.27%-27.56M
Net non-operating interest income expense	-47.46%-1.16M	-34.22%-1.37M	-8.18%-1.11M	-29.35%-4.67M	-81.88%-1.84M	22.97%-788K	-25.31%-1.02M	-34.25%-1.03M	-71.27%-3.61M	-33.60%-1.01M
Non-operating interest expense	47.46%1.16M	34.22%1.37M	8.18%1.11M	29.35%4.67M	81.88%1.84M	-22.97%788K	25.31%1.02M	34.25%1.03M	71.27%3.61M	33.60%1.01M
Other net income (expense)	-34.80%-829K	-838.28%-1.54M	3,975.00%815K	83.25%-459K	-621.43%-73K	-486.79%-615K	106.80%209K	-87.65%20K	-471.27%-2.74M	-84.78%14K
Gain on sale of security	---9K	--4K	--627K	----	----	----	----	----	----	----
Special income (charges)	---793K	---1.62M	----	83.88%-520K	---520K	--0	--0	----	---3.23M	--0
-Less:Impairment of capital assets	----	--1.62M	----	----	----	----	--0	----	----	----
-Less:Other special charges	----	----	----	-83.88%520K	----	----	----	----	--3.23M	--0
-Gain on sale of property,plant,equipment	---793K	----	----	----	----	--0	----	----	----	----
Other non- operating income (expenses)	95.61%-27K	-66.99%69K	840.00%188K	-87.45%61K	3,092.86%447K	-486.79%-615K	38.41%209K	-87.65%20K	-34.15%486K	-84.78%14K
Income before tax	59.35%-12.38M	31.34%-20.87M	15.29%-25.2M	6.69%-113.6M	19.46%-23M	9.28%-30.46M	3.64%-30.4M	-5.95%-29.75M	-30.55%-121.75M	1.06%-28.56M
Income tax	-115.89%-17K	42.94%233K	25.00%145K	117.29%930K	460.82%544K	-31.41%107K	207.55%163K	-4.92%116K	4.65%428K	-48.40%97K
Net income	59.55%-12.36M	30.95%-21.1M	15.14%-25.34M	6.26%-114.53M	17.84%-23.54M	9.39%-30.56M	3.28%-30.56M	-5.91%-29.86M	-30.44%-122.18M	1.37%-28.65M
Net income continuous Operations	59.55%-12.36M	30.95%-21.1M	15.14%-25.34M	6.26%-114.53M	17.84%-23.54M	9.39%-30.56M	3.28%-30.56M	-5.91%-29.86M	-30.44%-122.18M	1.37%-28.65M
Minority interest income
Net income attributable to the parent company	59.55%-12.36M	30.95%-21.1M	15.14%-25.34M	6.26%-114.53M	17.84%-23.54M	9.39%-30.56M	3.28%-30.56M	-5.91%-29.86M	-30.44%-122.18M	1.37%-28.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	59.55%-12.36M	30.95%-21.1M	15.14%-25.34M	6.26%-114.53M	17.84%-23.54M	9.39%-30.56M	3.28%-30.56M	-5.91%-29.86M	-30.44%-122.18M	1.37%-28.65M
Basic earnings per share	74.91%-1.42	53.16%-3.78	58.93%-4.6	43.29%-26.2	61.11%-4.2	55.08%-5.66	31.61%-8.07	-1.82%-11.2	2.53%-46.2	12.90%-10.8
Diluted earnings per share	74.91%-1.42	53.16%-3.78	58.93%-4.6	43.29%-26.2	61.11%-4.2	55.08%-5.66	31.61%-8.07	-1.82%-11.2	2.53%-46.2	12.90%-10.8
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data